Melanoma Genomics.

Area of Science:

• Genetics
• Epidemiology
• Dermatology

Background:

• Cutaneous melanoma incidence is increasing globally, particularly in fair-skinned populations.
• Genetically determined factors like pale skin, red hair, and numerous melanocytic nevi are established melanoma risk phenotypes.
• Genome-wide association studies (GWAS) have implicated pigmentation and melanocytic nevus development genes in melanoma risk.

Purpose of the Study:

• To review genetic factors contributing to melanoma susceptibility.
• To explore the role of pigmentation genes, nevus development genes, and telomere length genes in melanoma risk.
• To identify common and rare germline and somatic mutations associated with melanoma.

Main Methods:

• Review of epidemiological studies and genome-wide association studies (GWAS).
• Analysis of identified genetic risk factors, including pigmentation, melanocytic nevi, and telomere length genes.
• Examination of germline mutations in high-risk susceptibility genes (e.g., CDKN2A, CDK4, POT1, TERT) and somatic mutations (e.g., BRAF, NRAS, NF1, TP53).

Main Results:

• Pigmentation genes and genes related to melanocytic nevi are common genetic risk factors for melanoma.
• Genes associated with telomere length (e.g., POT1, TERT) are unexpectedly identified as melanoma risk genes.
• CDKN2A is the most frequent high-risk susceptibility gene; BRAF is the most common somatic driver mutation, followed by NRAS and NF1.

Conclusions:

• Genetic predisposition plays a significant role in melanoma development, involving pigmentation, nevus formation, and telomere maintenance pathways.
• While familial melanoma genes often correlate with increased nevi, the atypical nevus phenotype is an imperfect marker for gene carrier status.
• Understanding these genetic underpinnings is crucial for melanoma risk assessment and potentially targeted therapies, noting that BRAF and NRAS mutations may not be solely UV-induced.